Introduction to Nucl..
Download
Report
Transcript Introduction to Nucl..
Introduction to Nuclear Cardiology II
Principles of Instrumentation and Radiopharmacy
Matthew M. Schumaecker, MD, FACC
Carilion Clinic / VTSOM
Assistant Professor of Medicine
Objectives
Become familiar with the terminology used in nuclear
imaging
Become familiar with the concepts underlying nuclear
perfusion imaging
Become familiar with 99mTc and 201Tl as
radiopharmaceuticals
Preliminary exposure to instrumentation, image
acquisition and processing
Tutorial: how to read a scan
Become familiar with prognostic data associated with
nuclear imaging
Corollary concepts
Principles of nuclear physics
Principles of risk stratification
Principles of stress testing
Principles of radiation safety
PET imaging
MPI - The Basic Process
1.
2.
3.
4.
5.
6.
7.
Radioisotope is injected into patient.
Radioisotope is taken up into certain cells.
Radioisotope decays emitting gamma-photons
.
Gamma photons are detected by NaI/CZT
crystal.
Gamma photons are transformed into visible
photons by NaI/CZT crystal.
Visible photons are turned into electrons by a
photomultiplier tube.
Electrons convert to digital signal.
MPI - The Basic Process
Slide from E. Lindsay Tauxe ASNC, 7/2007
Compton Scatter and Collimators
A lot of Compton
Scatter
Collimators minimize
compton scatter
201Thallium
– Physical Properties
Produced offisite by a cyclotron
Physical t1/2 = 73 hours
Biological t1/2 = 10 days
Principal photon energies = 68-80 kEV
Prolonged half life limits total dose to 24mCi
201Thallium
Monovalent Cation
Some uptake via active transport
K+
K+
Tl+
Rb+
ATPase
Na+
Tl+
201Thallium
- Redistribution
Around 4% of the dose is rapidly taken up
by the myocardium – this demonstrates
coronary flow.
After initial extraction, there is
continuous exchange of thallium between
myocyte and intracellular compartment –
this demonstrates viability.
201Thallium
Advantages
Widely used
Less expensive than
technetium
High myocardial
extraction fraction
Good linearity of
uptake vs. flow
Disadvantages
Long half-life limits
maximal dose to 4.5
mCi
Substantial portion
of photons scatter
Low-energy photons
are easily attenuated
99mTechnetium
Also emits photons by gamma-decay
T1/2 is 6 hours
◦ This allows much higher dosing
Higher photo peak (~140 kEV)
◦ This causes less photon scatter and attenuation
Three 99mTc agents are approved:
1.
2.
3.
Sestamibi (Cardiolite)
Tetrofosmin (Myoview)
Teboroxime (Cardiotec) – not currently available
Sestamibi
Lipophilic monovalent cation
Na/K/ATPase pump not used
Exact mechanism of myocardial uptake is unclear
Appears to be passive across the plasma
membrane and mitochondrial membrane
Becomes sequestered in the mitochondria
because of the negative membrane potential
Therefore only minimal, if any, redistribution
occurs with sestamibi.
Sestamibi
Non-linearity of uptake vs. coronary flow
Slide from Dr. Gary Heller ASNC, 7/2007
Sestamibi
Advantages
Higher dose can be given
because of short half life
Lack of redistribution –
can obtain multiple
images over several
hours
Can obtain perfusion
imaging and gating in one
study
Disadvantages
Non-linear extraction
60% first-pass extraction
Lack of redistribution –
need 2 injections; limited
viability information
Excretion in
hepatobiliary system
Tetrofosmin
Lipophilic, cationic diphosphine
compound
Similar uptake mechanism as Sestamibi
Quick clearance from the liver
Slow clearance from the heart
Sestambi vs Tetrofosmin
Soman et. al
Sestambi vs Tetrofosmin
Soman et. al
REVIEW
Stress Modality: Dobutamine
Beta agonist
Simulates exercise by positive chronotropy
and inotropy.
Can be difficult to achieve 85% MPHR with
dobutamine alone
May need to augment chronotrophic
response with atropine up to 1 mg.
Can cause SAM and LVOT obstruction in
patients with significant septal hypertrophy.
REVIEW
Stress Modality:Vasodilator
Slide by Dr. Robert Hendel. ASNC 7/07
REVIEW
Stress Modality:Vasodilator
Slide by Dr. Robert Hendel. ASNC 7/07
REVIEW
Stress Modality: Adenosine
Causes coronary arteriolar vasodilation
Extremely short half life
Given in a four or six minute infusion
Tracer is injected halfway through the
protocol
Can cause flushing, diaphoresis,
chest pain. Usually resolves within
minutes after infusion
Stress Modality: Dipyridamole
Trade Name: Persantine
Acts by blocking the cellular uptake of
adenosine
Four to ten times less expensive than adenosine
Comparable to adenosine with respect to
sensitivity; specificity may be lower
Much longer half life so adverse reactions tend
to be more severe
Segmental Scoring
0 = Normal
1 = Slight reduction of uptake
2 = Moderate reduction of uptake
3 = Severe reduction of uptake
4 = Absent uptake
Segmental Scoring
Most outcome data uses old 20-segment
model
0-4 Normal
4-8 Mildly abnormal
9-13 Moderately abnormal
>13 Severely abnormal
In 17-segment model >11 is severely abnormal
SPECT - Prognostic Value
Slide from Dr. Robert Hendel ASNC, 7/2007
SPECT - Prognostic Value
Slide from Dr. Robert Hendel ASNC, 7/2007
Gated Images - Prognostic Value
Slide from Dr. Robert Hendel ASNC, 7/2007
SPECT vs. Direct Cath - Outcomes
Slide from Dr. Robert Hendel ASNC, 7/2007
SPECT vs. Direct Cath - Outcomes
Slide from Dr. Donna Polk ASNC, 7/2007
Attenuation Correction
Slide from Dr. Robert Hendel ASNC, 7/2007
Attenuation Correction
Slide from Dr. Robert Hendel ASNC, 7/2007
Attenuation Correction
Slide from Dr. Robert Hendel ASNC, 7/2007
Special Considerations
Slide from E. Lindsay Tauxe ASNC, 7/2007
Cardiac SPECT - Conclusions
Excellent prognostic information
◦
◦
◦
◦
Can tell likelihood of angiographically significant CAD and
Likelihood of a cardiac event
Negative study is very powerful
LV function data
Excellent diagnostic accuracy
◦ With all tracers and stress modalities
◦ Additive benefit of supine/prone
◦ Additive benefit of attenuation correction
Safe and cost-effective gatekeeper to the cath lab